Stocks and Investing
Stocks and Investing
Tue, May 16, 2017
[ 07:45 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Isaac Ro Initiated (ABT) at Hold and Held Target at $45 on, May 16th, 2017
Isaac Ro of Goldman Sachs, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $45 on, May 16th, 2017.
Isaac has made no other calls on ABT in the last 4 months.
There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, all agrees with Isaac's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joanne Wuensch of "BMO Capital" Downgraded from Buy to Hold on, Tuesday, March 14th, 2017
Contributing Sources